BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22274868)

  • 1. DNA methylation status of REIC/Dkk-3 gene in human malignancies.
    Hayashi T; Asano H; Toyooka S; Tsukuda K; Soh J; Shien T; Taira N; Maki Y; Tanaka N; Doihara H; Nasu Y; Huh NH; Miyoshi S
    J Cancer Res Clin Oncol; 2012 May; 138(5):799-809. PubMed ID: 22274868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced expression of the REIC/Dkk-3 gene by promoter-hypermethylation in human tumor cells.
    Kobayashi K; Ouchida M; Tsuji T; Hanafusa H; Miyazaki M; Namba M; Shimizu N; Shimizu K
    Gene; 2002 Jan; 282(1-2):151-8. PubMed ID: 11814687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. REIC/Dkk-3 induces cell death in human malignant glioma.
    Mizobuchi Y; Matsuzaki K; Kuwayama K; Kitazato K; Mure H; Kageji T; Nagahiro S
    Neuro Oncol; 2008 Jun; 10(3):244-53. PubMed ID: 18443132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of adenovirus-mediated REIC/Dkk-3 gene therapy for use in the treatment of pancreatic cancer.
    Uchida D; Shiraha H; Kato H; Nagahara T; Iwamuro M; Kataoka J; Horiguchi S; Watanabe M; Takaki A; Nouso K; Nasu Y; Yagi T; Kumon H; Yamamoto K
    J Gastroenterol Hepatol; 2014 May; 29(5):973-83. PubMed ID: 24372695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-cancer effects of REIC/Dkk-3-encoding adenoviral vector for the treatment of non-small cell lung cancer.
    Shien K; Tanaka N; Watanabe M; Soh J; Sakaguchi M; Matsuo K; Yamamoto H; Furukawa M; Asano H; Tsukuda K; Nasu Y; Huh NH; Miyoshi S; Kumon H; Toyooka S
    PLoS One; 2014; 9(2):e87900. PubMed ID: 24498395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis.
    Kashiwakura Y; Ochiai K; Watanabe M; Abarzua F; Sakaguchi M; Takaoka M; Tanimoto R; Nasu Y; Huh NH; Kumon H
    Cancer Res; 2008 Oct; 68(20):8333-41. PubMed ID: 18922905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression of REIC/Dkk-3 gene in non-small cell lung cancer.
    Nozaki I; Tsuji T; Iijima O; Ohmura Y; Andou A; Miyazaki M; Shimizu N; Namba M
    Int J Oncol; 2001 Jul; 19(1):117-21. PubMed ID: 11408931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer.
    Yu J; Tao Q; Cheng YY; Lee KY; Ng SS; Cheung KF; Tian L; Rha SY; Neumann U; Röcken C; Ebert MP; Chan FK; Sung JJ
    Cancer; 2009 Jan; 115(1):49-60. PubMed ID: 19051296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin antagonist augments the therapeutic effect of adenovirus-mediated REIC/Dkk-3 gene therapy for malignant glioma.
    Shimazu Y; Kurozumi K; Ichikawa T; Fujii K; Onishi M; Ishida J; Oka T; Watanabe M; Nasu Y; Kumon H; Date I
    Gene Ther; 2015 Feb; 22(2):146-54. PubMed ID: 25394252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of REIC/Dkk-3 in human renal clear cell carcinoma.
    Kurose K; Sakaguchi M; Nasu Y; Ebara S; Kaku H; Kariyama R; Arao Y; Miyazaki M; Tsushima T; Namba M; Kumon H; Huh NH
    J Urol; 2004 Mar; 171(3):1314-8. PubMed ID: 14767340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of the feline tumour suppressor reduced expression in immortalized cells (REIC/Dkk-3).
    Ochiai K; Oda H; Shono S; Kato Y; Sugihara S; Nakazawa S; Azakami D; Michishita M; Onozawa E; Bonkobara M; Sako T; Shun-Ai L; Ueki H; Watanabe M; Omi T
    Vet Comp Oncol; 2017 Dec; 15(4):1181-1186. PubMed ID: 27353749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. REIC/Dkk-3 stable transfection reduces the malignant phenotype of mouse prostate cancer RM9 cells.
    Chen J; Watanabe M; Huang P; Sakaguchi M; Ochiai K; Nasu Y; Ouchida M; Huh NH; Shimizu K; Kashiwakura Y; Kaku H; Kumon H
    Int J Mol Med; 2009 Dec; 24(6):789-94. PubMed ID: 19885619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulated REIC expression in lung carcinogenesis: a molecular target for gene therapy.
    Yang L; Zhao S; Xia P; Zheng HC
    Histol Histopathol; 2018 Jul; 33(7):691-704. PubMed ID: 29341059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor suppressor REIC/DKK-3 and co-chaperone SGTA: Their interaction and roles in the androgen sensitivity.
    Ochiai K; Morimatsu M; Kato Y; Ishiguro-Oonuma T; Udagawa C; Rungsuriyawiboon O; Azakami D; Michishita M; Ariyoshi Y; Ueki H; Nasu Y; Kumon H; Watanabe M; Omi T
    Oncotarget; 2016 Jan; 7(3):3283-96. PubMed ID: 26658102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel extracellular role of REIC/Dkk-3 protein in PD-L1 regulation in cancer cells.
    Gohara Y; Tomonobu N; Kinoshita R; Futami J; Audebert L; Chen Y; Komalasari NLGY; Jiang F; Yoshizawa C; Murata H; Yamamoto KI; Watanabe M; Kumon H; Sakaguchi M
    J Mol Med (Berl); 2023 Apr; 101(4):431-447. PubMed ID: 36869893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression pattern of REIC/Dkk-3 in various cell types and the implications of the soluble form in prostatic acinar development.
    Zhang K; Watanabe M; Kashiwakura Y; Li SA; Edamura K; Huang P; Yamaguchi K; Nasu Y; Kobayashi Y; Sakaguchi M; Ochiai K; Yamada H; Takei K; Ueki H; Huh NH; Li M; Kaku H; Na Y; Kumon H
    Int J Oncol; 2010 Dec; 37(6):1495-501. PubMed ID: 21042718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cysteine-rich core domain of REIC/Dkk-3 is critical for its effect on monocyte differentiation and tumor regression.
    Kinoshita R; Watanabe M; Huang P; Li SA; Sakaguchi M; Kumon H; Futami J
    Oncol Rep; 2015 Jun; 33(6):2908-14. PubMed ID: 25823913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promising therapeutic efficacy of a novel reduced expression in immortalized cells/dickkopf-3 expressing adenoviral vector for hepatocellular carcinoma.
    Sawahara H; Shiraha H; Uchida D; Kato H; Kato R; Oyama A; Nagahara T; Iwamuro M; Horiguchi S; Tsutsumi K; Mandai M; Mimura T; Wada N; Takeuchi Y; Kuwaki K; Onishi H; Nakamura S; Watanabe M; Sakaguchi M; Takaki A; Nouso K; Yagi T; Nasu Y; Kumon H; Okada H
    J Gastroenterol Hepatol; 2017 Oct; 32(10):1769-1777. PubMed ID: 28168749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological aspects of REIC/Dkk-3 in monocyte differentiation and tumor regression.
    Watanabe M; Kashiwakura Y; Huang P; Ochiai K; Futami J; Li SA; Takaoka M; Nasu Y; Sakaguchi M; Huh NH; Kumon H
    Int J Oncol; 2009 Mar; 34(3):657-63. PubMed ID: 19212670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel gene expression system strongly enhances the anticancer effects of a REIC/Dkk-3-encoding adenoviral vector.
    Watanabe M; Sakaguchi M; Kinoshita R; Kaku H; Ariyoshi Y; Ueki H; Tanimoto R; Ebara S; Ochiai K; Futami J; Li SA; Huang P; Nasu Y; Huh NH; Kumon H
    Oncol Rep; 2014 Mar; 31(3):1089-95. PubMed ID: 24398705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.